Background: Iliac artery stenosis or occlusion is a critical condition that can severely impact a patient's quality of life. The effectiveness of balloon angioplasty and intraluminal stenting for the treatment of iliac artery lesions classified as TASC II A and B was evaluated in this single-center prospective study.Methods: Conducted between October 2016 and September 2020 at Cho Ray Hospital's Vascular Surgery Department, this prospective study involved PAD patients categorized by TASC II A and B classifications who underwent endovascular intervention. Intervention outcomes were assessed peri-procedure and during short-term and mid-term follow-ups.Results: Of the total of 133 patients, 34.6% underwent balloon angioplasty, while 65.4% received stenting. The immediate technical success rate was 97.7%, while the clinical success rate was 62.4%. Complications were minimal, with major limb amputation reported in 1.5% of the cases. There was a significant improvement in Rutherford classification and ABI at short-term follow-up, with a patency rate of 90.2%. The mid-term post-intervention follow-up yielded similar results with an 86.1% patency rate. The mortality rates associated with arterial occlusion were 2.3% during short-term follow-up and 1.7% during mid-term follow-up.Conclusion: Balloon angioplasty and stent placement are effective and safe interventions for TASC II A and B iliac artery occlusions with favorable short and mid-term outcomes. Further, multi-center studies with larger sample sizes are recommended for more comprehensive conclusions, including long-term follow-up assessment.

Catastrophic pelvic and perineal trauma with associated traumatic hemipelvectomy is extremely rare and carries a high mortality risk. These injuries often

Background: The study was aimed at evaluating the efficacy, safety, and outcomes of endovascular intervention (EVT) among patients with acute inferior deep vein thrombosis (DVT), as well as revealing the risk factors associated with postthrombotic syndrome (PTS) in these patients. Methods: This retrospective study was conducted at the Department of Vascular Surgery, C.R. Hospital, Vietnam. The study enrolled all the patients diagnosed with acute lower limb DVT and underwent EVT (thromboaspiration, thrombolysis, balloon angioplasty, and stent placement) between January 2017 and December 2022. All the patients were recorded with treatment outcomes, postinterventional complications, and factors relating to PTS on the follow‐up at 1 week and at 1 month after intervention. Results: A total of 37 patients met the inclusion criteria. Baseline characteristics included a mean age of 55.8 ± 13.3 years, female sex (75.5%), body mass index (BMI) ≥ 23 kg/m ² (63.2%), and inferior DVT on the left side (91.9%). Location of thrombus was noted at the iliac vein (97.3%), the femoral vein (70.3%), and the popliteal vein (97.3%). Postoperative length of stay was 5.5 ± 2.7 days, and clinical symptoms reduced in 2.5 ± 0.9 days. There were two cases of bleeding at the interventional site and two cases of death. Partial stenosis at 1 week and 1 month regarding the iliac vein, the femoral vein, and the popliteal vein was 71.4% and 54.3%, 14.3% and 37.1%, and 20.0% and 40.0%, respectively. None of the cases were observed with complete stenosis. In addition, 62.9% of cases reported no PTS. 37.1% of cases were noted with mild PTS. Advanced age, high BMI, duration time of thrombolysis, and underlying diseases were all associated factors relating to PTS. Noticeably, comorbidities and overweight/obesity increased 18.7‐ and 17.33‐fold risk of PTS ( p < 0.05), respectively. Conclusions: EVT is an acceptable alternative method in the treatment of acute inferior DVT. A decision‐making of EVTs for acute lower limb DVT should be implemented after assessment of risk factors in large centers with professional conditions and facilities.

Background Pediatric coronary artery disease is rare and heterogeneous, with potentially severe clinical consequences. Data from resource-limited settings remains limited. This study aims to describe the clinical presentation and surgical management of pediatric coronary artery disease at a tertiary cardiac surgery center. Methods We performed a single-center retrospective case series of pediatric patients who underwent surgical intervention for coronary artery disease between 2018 and 2025. Demographic data, coronary pathology, surgical procedures, and early outcomes were analyzed. Results Eight patients (median age 10 years) were included. Fatigue was reported in four patients (50%) and chest pain in two (25%), and most patients had heart failure at presentation. Etiologies included Kawasaki disease-related coronary pathology in three patients (37.5%), anomalous coronary artery origin in three (37.5%, including one case of anomalous left coronary artery from the pulmonary artery (ALCAPA)), coronary artery fistula in two (25%), and tetralogy of Fallot-associated coronary anomalies in two (25%). Eleven surgical procedures were performed, with coronary artery bypass grafting being the most frequent approach (five procedures, 46%). Cardiopulmonary bypass was used in seven patients (87.5%). No early operative mortality was observed. Conclusions Pediatric coronary artery disease is heterogeneous and requires pathology-specific surgical strategies. Individualized surgical management was feasible with favorable early outcomes in a tertiary pediatric cardiac surgery center.

Neurofibromatosis is considered a rare genetic disorder primarily affecting neural tissues. The most common type is neurofibromatosis type 1, which is characterized by plexiform neurofibromas. We report a case of a 30-year-old Rag-lay ethnic woman with facial plexiform neurofibroma, which not only infiltrated the left eye socket but also caused destruction of temporal bone and facial deformity. The disease started in her childhood, and she had numerous neurofibromas on her trunk and limb at the time of the hospital admission. The patient was diagnosed with neurofibromatosis 1 based on clinical symptoms, computed tomography images, and histopathologic result. For safety, we divided treatment into two phases. For the first phase, we dealt with the blood supply and meningeal suture, and then we performed surgical resection and skin flap reconstruction surgery. The main therapy for plexiform neurofibroma is surgery, which aims at tumor removal and management of complications. However, the treatment plan is different in each case based on the nature and extent of tumor, which requires more verification and clinical practice.

Diffuse supravalvular aortic stenosis (SVAS) is rare, especially in nonsyndromic patients and becomes more complex when the aortic arch branches are involved. Surgical planning must consider sinus dimensions to minimize the postoperative complications. We describe a 7-year-old boy without Williams–Beuren syndrome who was found to have diffuse SVAS extending from the sinotubular junction to the aortic isthmus, with additional narrowing of the brachiocephalic and left common carotid arteries. Because the aortic sinuses were normal in size, a sinus-sparing aortoplasty with patch augmentation of the stenotic aortic and arch-branch segments was performed. Sinus-sparing aortoplasty is a valuable surgical option in diffuse SVAS when the aortic sinuses are of normal size, allowing the effective relief of obstruction while minimizing the risk of postoperative aortic regurgitation and coronary ischemia.